Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,744 total, page 31 of 35

TERMINATED Phase 2

Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma

NCT00481832

TERMINATED Phase 2

Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy

NCT00490490

COMPLETED

The Effects of High and Low Blood Glucose Values on the Brain in Children With Type 1 Diabetes Mellitus

NCT01690481

COMPLETED Phase 1

Exercise Therapy to Treat Adults With Abdominal Aortic Aneurysms

NCT00349947

TERMINATED Phase 4

Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction

NCT00398632

COMPLETED NA

Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx

NCT00767273

COMPLETED NA

Understanding Pine Bark Extract as an Alternative Treatment (UPBEAT) Study

NCT00425945

TERMINATED Phase 2

Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT

NCT00482053

TERMINATED NA

Treatment of Insulin Resistance in Hypertensive, Obese Adolescents

NCT00185705

COMPLETED Phase 2

Extended Cessation Treatment for Teen Smokers

NCT00459953

COMPLETED

Evaluation of Preexisting Immunity Markers in Human Tumor Tissue Sample

NCT00568867

COMPLETED

Sleep, Circadian Hormonal Dysregulation, and Breast Cancer Survival

NCT00519168

COMPLETED Phase 2

Fulvestrant in Hormone Refractory Prostate Cancer

NCT00476645

COMPLETED NA

Imaging Study of Chronic Low Back Pain in Patients Taking Pain Medication

NCT00388414

COMPLETED NA

Effect of Behavior Therapy on Responses to Social Stimuli in People With Social Phobia

NCT00380731

COMPLETED NA

Trial of Cervical Ripening and Labor Induction Using Misoprostol With or Without Intravaginal Isosorbide Mononitrate

NCT00374621

COMPLETED NA

Efficacy of Group Intervention to Reduce Stress Symptoms

NCT00611338

COMPLETED NA

A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease

NCT00350545

COMPLETED Phase 2

High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma

NCT00349778

COMPLETED NA

Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD

NCT00363298

COMPLETED Phase 2

Raloxifene for Women With Alzheimer's Disease

NCT00368459

COMPLETED NA

Wavefront-guided Photorefractive Keratectomy (PRK) Versus Wavefront-guided Lasik for Myopia

NCT01140594

COMPLETED Phase 2

Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT

NCT00350181

TERMINATED Phase 2

Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT

NCT01220297

TERMINATED Phase 2

Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus

NCT00285779

TERMINATED

Identification of Key Blood Molecular Markers for Immunotherapy

NCT00507702

COMPLETED NA

Behavioral Strategies for Weight Management

NCT00575731

COMPLETED Phase 4

Using the SEDLine for the Titration of Sevoflurane in Elderly Patients Recovery Using the SEDLine TM for the Titration of Sevoflurane in Elderly Patients Undergoing Non-Cardiac Surgery After Beta-Adrenergic Blockade

NCT00938782

COMPLETED NA

Treating Tobacco Dependence in Inpatient Psychiatry - 1

NCT00136812

COMPLETED

Symptom Assessment With Patient Surveys

NCT01135823

COMPLETED Phase 3

Comparison of Two Types of Family Therapy in the Treatment of Adolescent Anorexia Nervosa

NCT00610753

TERMINATED Phase 2

Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer

NCT00477087

COMPLETED

Diagnostic Utility of MRI in Intracerebral Hemorrhage

NCT00363662

COMPLETED Phase 2

Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer

NCT00323869

COMPLETED NA

Pain Study of Rectus Muscle Closure at Cesarean Delivery

NCT00505362

TERMINATED Phase 1

Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer

NCT00368329

COMPLETED Phase 2

Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia.

NCT00383643

COMPLETED NA

Sports to Prevent Obesity

NCT00318877

COMPLETED

Side Effects of Antipsychotic Medications

NCT00363181

COMPLETED NA

Internet Diabetes Self-Management Workshop

NCT00185601

COMPLETED Phase 2

Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases

NCT00375830

COMPLETED NA

Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)

NCT00267774

COMPLETED NA

Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression

NCT00285727

COMPLETED

Age-related Longitudinal Changes in Aviator Performance

NCT01364753

COMPLETED Phase 1

Memantine Augmentation in Obsessive-Compulsive Disorder

NCT00264238

COMPLETED

Mild Depression 2 Week Observational Study

NCT00285831

COMPLETED Phase 1

Stanford Preschool Physical Activity Project

NCT00285792

COMPLETED Phase 2

Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease

NCT00388362

COMPLETED NA

Heparin and the Reduction of Thrombosis (HART) Trial

NCT00779558

TERMINATED Phase 2

Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention

NCT00285857

← Previous Page 31 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.